Major depressive disorder trials recruiting in Alabama

All Major depressive disorder trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Alabama: Dothan, Huntsville
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
  NCT07276997 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Alabama: Dothan
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Huntsville
• MicroRNA Correlates of Childhood Maltreatment and Suicidality
  NCT04923685 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · Alabama: Birmingham, Huntsville
• NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06911112 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Huntsville
• Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
  NCT05437588 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 24 Years · Sex: All (male and female) · Alabama: Birmingham, Huntsville
• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
  NCT06633016 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Alabama: Birmingham
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
  NCT05850689 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Alabama: Huntsville
• Using TMS to Understand Neural Processes of Social Motivation
  NCT06274112 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 50 Years · Sex: All (male and female) · Alabama: Auburn
• Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT06547489 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Alabama: Birmingham, Huntsville